University of Chicago

Company

Related News

CGT Manufacturing Shifts Toward Industrialization and Process Consolidation

Cell and gene therapy manufacturing is shifting from scientific feasibility toward industrialization, with industry leaders emphasizing process consolidation, closed workflows, and digital quality systems to enable scalable, reproducible production. Insights from the Advanced Therapies USA conference highlighted that sustainable CGT commercialization depends on manufacturability at scale, with a US$40 million grant program and single-workflow bioreactor data demonstrating practical steps toward that goal.

Related Clinical Trials

NCT ID Title Status Phase
NCT07716592

PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients

NOT_YET_RECRUITING NA
NCT07713849

Transition Care for FEP

RECRUITING
NCT07700368

Effect of Monosodium Glutamate on Microbiome-Derived Imidazole Propionate Production in Healthy Volunteers

NOT_YET_RECRUITING NA
NCT07692945

Biasing Food Value Construction

NOT_YET_RECRUITING NA
NCT07672301

Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty

RECRUITING PHASE1/PHASE2
NCT07666139

The 'Comprehensive Adherence Resource and Empowerment Support' (CARES) Study

NOT_YET_RECRUITING NA
NCT07664631

Effects of Stimulant Medications in PTSD

NOT_YET_RECRUITING PHASE1
NCT07636213

BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence

NOT_YET_RECRUITING
NCT07603856

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

RECRUITING PHASE2
NCT07592000

Breakthrough - T1DM and Chronic Kidney Disease

RECRUITING PHASE1/PHASE2